TG Therapeutics (TGTX) Reports Q4 Loss of $0.48/Share
Get Alerts TGTX Hot Sheet
Join SI Premium – FREE
TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.48), versus ($0.37) reported last year.
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- Morgan Stanley sees quality stocks and AI adopters leading market
- H.B. Fuller board rejects Ancora's $1.1B-$1.2B BAS unit bid
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share